These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 24069634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
    Mihalak KB, Carroll FI, Luetje CW.
    Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
    Wecker L, Engberg ME, Philpot RM, Lambert CS, Kang CW, Antilla JC, Bickford PC, Hudson CE, Zesiewicz TA, Rowell PP.
    Neuropharmacology; 2013 Oct; 73():75-86. PubMed ID: 23711550
    [Abstract] [Full Text] [Related]

  • 8. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats.
    Goutier W, Kloeze MB, McCreary AC.
    Addict Biol; 2015 Mar; 20(2):248-58. PubMed ID: 24251901
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nicotine-motivated behavior in Caenorhabditis elegans requires the nicotinic acetylcholine receptor subunits acr-5 and acr-15.
    Sellings L, Pereira S, Qian C, Dixon-McDougall T, Nowak C, Zhao B, Tyndale RF, van der Kooy D.
    Eur J Neurosci; 2013 Mar; 37(5):743-56. PubMed ID: 23351035
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Non-nicotinic therapies for smoking cessation.
    Siu EC, Tyndale RF.
    Annu Rev Pharmacol Toxicol; 2007 Mar; 47():541-64. PubMed ID: 17209799
    [Abstract] [Full Text] [Related]

  • 15. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD, O'Neill BT.
    J Med Chem; 2005 May 19; 48(10):3474-7. PubMed ID: 15887955
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area.
    Reperant C, Pons S, Dufour E, Rollema H, Gardier AM, Maskos U.
    Neuropharmacology; 2010 Feb 19; 58(2):346-50. PubMed ID: 19887076
    [Abstract] [Full Text] [Related]

  • 18. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
    Crunelle CL, Miller ML, Booij J, van den Brink W.
    Eur Neuropsychopharmacol; 2010 Feb 19; 20(2):69-79. PubMed ID: 19959340
    [Abstract] [Full Text] [Related]

  • 19. Varenicline improves mood and cognition during smoking abstinence.
    Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C.
    Biol Psychiatry; 2009 Jan 15; 65(2):144-9. PubMed ID: 18842256
    [Abstract] [Full Text] [Related]

  • 20. Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
    Turner JR, Castellano LM, Blendy JA.
    J Pharmacol Exp Ther; 2010 Aug 15; 334(2):665-72. PubMed ID: 20435920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.